Drug intelligence / Profile preview

Bio Blue 90 Plus

Development stage
Unknown
Lead developer
Biotech Healthcare
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

Bio Blue 90 Plus is a "heavy" ophthalmic staining solution composed of 0.05% w/v Brilliant Blue G (BBG) and 4% Polyethylene Glycol (PEG). Developed by Biotech Vision Care, it is used as a surgical aid during vitreoretinal procedures to selectively stain the internal limiting membrane (ILM). The addition of PEG increases the density of the solution, allowing the dye to sink rapidly through the vitreous cavity to the posterior pole and settle on the macula without necessitating a fluid-air exchange. This selective staining provides surgeons with high visual contrast, facilitating the safe and precise peeling of the ILM, which is a critical step in treating conditions such as macular holes, epiretinal membranes, and vitreomacular traction. The formulation is typically designed to be iso-osmolar and biocompatible to minimize the risk of retinal toxicity.

Brand names
Bio Blue 90 Plus
Other names
Bio-Blue 90 PlusBio-Blue90 PlusBio-Blue-90 PlusHeavy Brilliant Blue GBrilliant Blue G 0.05% with PEG

Beyond the preview

Go deeper on Bio Blue 90 Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bio Blue 90 Plus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call